World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01085357
Date of registration: 01/03/2010
Primary sponsor: Transcend Medical, Inc.
Public title: Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery COMPASS
Scientific title: A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery
Date of first enrolment: September 2009
Target sample size: 723
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01085357
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Ginger Clasby
Address: 
Telephone: 949-379-1962
Email:
Affiliation: 
Key inclusion & exclusion criteria

Preoperative Inclusion Criteria:

- Diagnosis of primary open angle glaucoma (POAG)

- Mean diurnal unmedicated IOP of 21 - 33 mmHg

- Normal anterior chamber angle anatomy at site of implantation

- Operable age-related cataract

Exclusion Criteria:

- Use of more than 3 ocular hypotensive medications (combination medications count as 2
medications)

- Significant risk associated with washout of ocular hypotensive medication

- Previous glaucoma surgery (with exception of laser treatments to the trabecular
meshwork)

- Previous corneal surgery

- Clinically significant ocular pathology, other than cataract and glaucoma

- Diagnosis of acute angle closure, traumatic, congenital, malignant, uveitic,
pseudoexfoliative, pigmentary or neovascular glaucoma



Age minimum: 45 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Cataract
Primary Open Angle Glaucoma (POAG)
Intervention(s)
Device: CyPass Micro-stent
Procedure: Cataract Surgery
Primary Outcome(s)
Proportion of eyes with = 20% decrease in intraocular pressure (IOP) from baseline to the hypotensive medication-free 24-month postoperative examination [Time Frame: 24 months postoperative]
Secondary Outcome(s)
Mean change in IOP between baseline and hypotensive medication-free 24-month postoperative examination [Time Frame: 24 months postoperative]
Proportion of eyes with postoperative IOP = 6 and = 18 mmHg, as measured by Goldmann Tonometry, at the hypotensive medication-free 24-month postoperative examination [Time Frame: 24 months postoperative]
Secondary ID(s)
TMI-09-01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history